In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method

International Journal of Pharmaceutics

Volumn 131, Issue 1, 1996, Pages 73-82

  Ciftci, Kadriye ^a,b   Kas, H Süheyla ^a   Hincal, A Atilla ^a   Ercan, T Meral ^a   Güven, Olgun ^a   Ruacan, Sevket ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

5 fluorouracil; Biodegradable microspheres; In vivo distribution; Poly (DL lactide co glycolide)

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TARGETING; DRUG TISSUE LEVEL; ENCAPSULATION; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PH; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 0029963556     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04369-1     Document Type: Article

References (26)

1. Bamba, M., Puisieux, F., Marty, J.P. and Carstensen, J.T., Release mechanism in gel forming sustained release preparations. Int. J. Pharm., 2 (1979) 307-315.
2. Boisdron-Celle, M., Menei, P.H. and Benoit, J.P., Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J. Pharm. Pharmacol., 47 (1995) 108-114.
3. Ciftci, K., Kas, H.S. and Hincal, A.A., Microspheres of 5-FU poly (DL-lactic acid): Effect of molecular weight on release characteristics. 6th Int. Conf. Pharm. Technol., Paris, France (1992a).
4. Ciftci, K., Kas, H.S., Güven, O. and Hincal, A.A., PLAGA microspheres of 5-FU: In vitro degradation and release characteristics. 6th Int. Pharm. Technol. Sym., Ankara, Turkey (1992b).
5. Ciftci, K. Hincal, A.A., Kas, H.S., Ercan, M. and Ruacan, S., Microspheres of 5-FU using poly (DL-lactic acid): In vitro release properties and distribution in mice after i.v. administration. Eur. J. Pharm., 1 (1994) 249-258.
6. Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L.H. and Langer, R., Controlled delivery systems for protein based on poly (lactic/glycolic acid) microspheres. Pharm. Res., 8 (1991) 713-720.
7. De Keyser, J.L., Poupaert, J.H. and Dumont, P., Poly (diethylmethylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. J. Pharm. Sci., 80 (1991) 67-70.
8. Duncan, R., Seymour, L.W., O'Hare, K.B., Flanagan, P.A. and Suarato, A., Preclinical evaluation of polymer-bound doxorubicin. J. Control. Rel., 19 (1992) 331-346.
9. Edman, P. and Sjoholm, I., Acrylic microspheres in vivo: VIII. Distribution and elimination of polyacryldextran particles in mice. J. Pharm. Sci., 72 (1983) 796-799.
10. 99mTc-labeled radiopharmaceuticals. Hacettepe Bull. Med. Surg., 9 (1976) 85-89.
11. Ercan, MT., Technetiurn-99m radiopharmaceutics. Hacettepe Univ. J. Pharm., 9 (1989) 69-84.
12. Gupta, P.K., Drug targeting in cancer chemotherapy: a clinical perspective. J. Pharm. Sci., 79 (1990) 949-962.
13. Heller, J., Biodegradable polymers in controlled drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 1 (1984) 39-90.
14. Higuchi, T., Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrix. J. Pharm. Sci., 52 (1963) 1145-1149.
15. Ilium, L., David, J.S., Wilson, C.G., Thomas, N.W., Frier, M. and Hardy, J.G., Blood clearance and organ deposition of intravenously administered colloidal particles. The effect of particle size, nature and shape. Int. J. Pharm., 12 (1985) 135-139.
16. Ilium, L. and Davis, S.S., Targeting of colloidal particles to the bone marrow. Life Sci., 40 (1987) 1553-1560.
17. Jalil, R., Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) polymers in sustained drug delivery. Drug Dev. Ind. Pharm., 16 (1990) 2353-2367.
18. Kim, C.K., Hwang, S.J. and Lee, M.G., Organ targetability of small and large albumin microspheres containing free and HSA conjugated methotrexate. Int. J. Pharm., 89 (1993) 91-102.
19. Kulkarni, R.K., Pani, K.C., Neuman, C. and Leonard, F., Polylactic acid for surgical implants. Arch. Surg., 93 (1966) 839-843.
20. Müller, R.H. and Wallis, K.H., Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908. Int. J. Pharm., 89 (1993) 25-31.
21. Ruiz, J.M., Busnel, J.P. and Benoit, J.P., Influence of average molecular weights of poly (DL-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro release from microspheres. Pharm. Res., 1 (1990) 928-934.
22. Saha, G.B., (Ed), Fundamentals of Nuclear Pharmacy, Springer-Verlag, New York, 1984, pp. 81-104.
23. Schindler, A., Jeffcoat, R., Kimmel, G.L., Pitt, C.G., Wall, W.E. and Zweidinger, R., Biodegradable polymers for sustained drug delivery. In Pearce, E.M. and Schaefgen, J.R. (Eds), Contemporary Topics in Polymer Science, Vol. 2, Plenum Press, NY 1977, pp. 251-289.
24. Shepherd, F.A., Rotstein, L., Houle, S., Yip, T.K., Paul, K. and Sniderman, K., A phase I dose escalation trial of yitrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer, 70 (1992) 2250-2254.
25. Skolnick, A.A., Novel treatments for liver cancer and other solid tumors show early promise. JAMA, 271 (1994) 1813-1815.
26. Vert, M., Li, S. and Garreau, H., More about the degradation of LA/GA-derived matrices in aqueous media. J. Control. Rel., 16 (1991) 15-26.